ID   SCTi004-A
AC   CVCL_E2TY
DR   BioSamples; SAMEA115048409
DR   hPSCreg; SCTi004-A
CC   From: STEMCELL Technologies, Inc.; Vancouver; Canada.
CC   Population: African American.
CC   HLA typing: A*34:02:01; B*44:03:02,52:01:02; C*07:01:01,16:01:01; DPB1*01:01:01,04:02:01; DQB1*02:01:01,05:01:01; DRB1*13:01:01,13:03:01; DRB3*01:01:02,02:02:01 (STEMCELL Technologies).
CC   Omics: Genome sequenced.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): STEMCELL Technologies
ST   Amelogenin: X,Y
ST   CSF1PO: 9,12
ST   D13S317: 11,12
ST   D16S539: 9,11
ST   D18S51: 15
ST   D21S11: 28,30
ST   D5S818: 8,10
ST   D7S820: 11,13
ST   D8S1179: 14,15
ST   FGA: 19,24
ST   Penta D: 9,11
ST   Penta E: 8,14
ST   TPOX: 11
ST   vWA: 14,15
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   23Y
CA   Induced pluripotent stem cell
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//